Successful bone marrow transplantation in a child with X-linked hyper-IgM syndrome

Bone Marrow Transplantation

Volumn 23, Issue 10, 1999, Pages 1081-1083

  Kato, T ^a   Tsuge, I ^b   Inaba, J ^a   Kato, K ^a   Matsuyama, T ^a   Kojima, S ^a  

^a JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone marrow transplantation; CD40 ligand; X linked hyper IgM syndrome

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; BUSULFAN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GLYCOPROTEIN GP 39; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LYMPHOCYTE ANTIBODY; METHOTREXATE; POLYMYXIN B;

ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; DONOR; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; HYPERIMMUNOGLOBULINEMIA; INFANT; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN EXPRESSION; SIBLING; T LYMPHOCYTE; TREATMENT OUTCOME;

EID: 0033014727     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701753     Document Type: Article

References (15)

1. Notarangelo LD, Duse M, Ugazio AG. Immunodeficiency with hyper-IgM (HIM). Immunodefic Rev 1992; 3: 101-122.
2. Allen RC, Armitage RJ, Conley ME et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 1993; 259: 990-993.
3. Korthäuer U, Graf D, Mages HW et al. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 1993; 361: 539-541.
4. DiSanto JP, Bonnefoy JY, Gauchat JF et al. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature 1993; 361: 541-543.
5. Aruffo A, Farrington M, Hollenbaugh D et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 1993; 72: 291-300.
6. Fuleihan R, Ramesh N, Loh R et al. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci USA 1993; 90: 2170-2173.
7. Armitage RJ, Fanslow WC, Strockbine L et al. Molecular and biological characterization of a murine ligand for CD40. Nature 1992; 357: 80-82.
8. Noelle RJ, Meenakshi R, Shepherd DM et al. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci USA 1992; 89: 6550-6554.
9. Banatvala N, Davies J, Kanariou M et al. Hypogamma-globulinaemia associated with normal or increased IgM (the hyper IgM syndrome): a case series review. Arch Dis Child 1994; 71: 150-152.
10. Levy J, Espanol-Boren T, Thomas C et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 1997; 131: 47-54.
11. Thomas C, de Saint Basile G, Le Deist F et al. Brief report: correction of X-linked hyper-IgM syndrome by allogeneic bone marrow transplantation. New Engl J Med 1995; 333: 426-429.
12. Buckley RH. Transplantation. In: Stiehm ER (ed). Immunologic Disorders in Infants and Children, 4th edn. WB Saunders: Philadelphia, 1996, pp 1014-1058.
13. Fischer A, Landais P, Friedrich W et al. Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: a report from the European group for BMT and the European Group for Immunodeficiency. Blood 1994; 83: 1149-1154.
14. Blazar BR, Ramsay NKC, Kersey JH et al. Pretransplant conditioning with busulfan (Myleran) and cyclophosphamide for nonmalignant diseases. Transplantation 1985; 39: 597-603.
15. Fuleihan R, Ramesh N, Horner A et al. Cyclosporin A inhibits CD40 ligand expression in T lymphocytes. J Clin Invest 1994; 93: 1315-1320.